Kalaris Therapeutics, Inc. (KLRS) › Total AssetsKalaris Therapeutics, Inc. (KLRS) — Total AssetsAnnual figures by period end, from SEC filings.2019-12-31: $139.42M2020-12-31: $370.82M2021-12-31: $286.59M2022-12-31: $277.08M2023-12-31: $190.80M2024-12-31: $6.16M2025-12-31: $121.74M$121.74M2019-12-31Total Assets (USD)2025-12-31Period endedTotal AssetsChange YoYSource filing2025-12-31$121.74M+1875.6%2026-03-17Balance as of period end2024-12-31$6.16M-96.8%2026-03-17Balance as of period end2023-12-31$190.80M-31.1%2025-03-07Balance as of period end2022-12-31$277.08M-3.3%2024-03-15Balance as of period end2021-12-31$286.59M-22.7%2023-02-15Balance as of period end2020-12-31$370.82M+166.0%2022-02-10Balance as of period end2019-12-31$139.42M—2021-02-12Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)